This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
User:SaraKathryn Kalkhoff/Sandbox 1
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | = Glucose-Dependent Insulinotropic Receptor/GIPR bound with Tirzepatide = | + | <scene name='10/1037492/Spinning_tirz/1'>Text To Be Displayed</scene>= Glucose-Dependent Insulinotropic Receptor/GIPR bound with Tirzepatide = |
<StructureSection load='7ra3' size='340' side='right' caption='GIP-R. PDB: 7ra3' scene='Scene_1'> | <StructureSection load='7ra3' size='340' side='right' caption='GIP-R. PDB: 7ra3' scene='Scene_1'> | ||
| Line 9: | Line 9: | ||
The GIP receptor helps facilitate movement of glucose within a cell. <ref name='Sun'>PMID:35333651</ref>. | The GIP receptor helps facilitate movement of glucose within a cell. <ref name='Sun'>PMID:35333651</ref>. | ||
===Tirzepatide=== | ===Tirzepatide=== | ||
| - | Tirzepatide has been used as a treatment for Type 2 diabetes. | + | Tirzepatide has been used as a treatment for Type 2 diabetes. <scene name='10/1037492/Spinning_tirz/1'>Tirzepatide has a total of 39 residues present in its structure.</scene> It is used to help treat Type 2 Diabetes, as a |
| - | <scene name='10/1037492/ | + | |
== Disease == | == Disease == | ||
Diabetes is very bad for you<ref name='Ransey'>PMID:28504306</ref>. | Diabetes is very bad for you<ref name='Ransey'>PMID:28504306</ref>. | ||
| Line 22: | Line 22: | ||
== References == | == References == | ||
<references/> | <references/> | ||
| - | |||
== Student Contributors == | == Student Contributors == | ||
SaraKathryn Kalkhoff | SaraKathryn Kalkhoff | ||
Camille Gaudet | Camille Gaudet | ||
</StructureSection> | </StructureSection> | ||
Revision as of 13:48, 2 April 2024
= Glucose-Dependent Insulinotropic Receptor/GIPR bound with Tirzepatide =
| |||||||||||
